ICG Fluorescence Imaging to Guide Head and Neck Free Flap Surgery
Official title: Comparing Intraoperative Indocyanine Green Fluorescence Imaging With Standard Clinical Assessment for Flap Perfusion in Head and Neck Reconstruction: A Randomised Controlled Trial (VISION Trial)
Run by Region Skane · NCT07635420 · Data updated 2026-11-12
This trial tests whether using intraoperative indocyanine green (ICG) fluorescence imaging helps surgeons improve flap outcomes compared with standard assessments in adults undergoing head and neck free flap reconstruction.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 244 (estimated) |
| Sponsor | Region Skane Academic / other |
| Locations | 1 site (Malmö) |
| Status | Recruiting |
| Started | September 28, 2026 |
| Main results expected | January 1, 2029 |
| Study ends | August 1, 2029 |
| Registry record updated | September 29, 2026 |
| Trial ID | NCT07635420 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (18 years or older) undergoing microvascular head and neck free flap reconstruction at participating centers who can provide informed consent.
✕Probably not a fit
Patients with contraindications to indocyanine green or iodine allergy may not benefit from the imaging approach.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This multicenter, open-label randomized trial compares intraoperative ICG fluorescence angiography plus standard perfusion assessment to standard clinical assessment alone in adult head and neck free flap reconstruction. Primary outcome is partial flap loss requiring intervention within 30 days post-surgery; secondary outcomes include total flap loss, flap-related re-exploration, flap salvage, and postoperative complications. The study aims to determine if real-time ICG visualization can improve perfusion assessment and reduce complications. Eligible participants are adults undergoing microvascular free flap reconstruction for oncologic, trauma, or benign head and neck defects at Swedish centers. The trial plans to enroll 244 participants across sites led by Region Skane, Skåne University Hospital, Malmö.
Why it matters
Potential benefit: If successful, the approach could reduce partial flap loss and related complications, potentially improving reconstructive success and patient recovery.
How similar studies have gone: Previous retrospective studies suggested benefits of ICG angiography for flap perfusion, but high-quality randomized evidence has been limited until now.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥18 years at the time of inclusion * Scheduled to undergo microvascular free flap reconstruction as part of oncologic, trauma, or benign surgery in the head and neck area * Ability to understand study information and provide written informed consent Exclusion Criteria: * Known allergy to indocyanine green or iodine * Severe hepatic or renal impairment * Confirmed or suspected pregnancy * Breastfeeding
Where it's running
-
Dept. of Plastic and Reconstructive Surgery and Dept. of Health Sciences, Skåne University Hospital, Malmö, Sweden.
Malmö, Sweden Recruiting
Study contacts
- Principal investigator: Pooya Rajabaleyan, MD, PhD — Region Skåne, Skånes universitetssjukhus, Sektion Plastikkirurgi, Malmö, Sverige
- Study coordinator: Pooya Rajabaleyan, MD, PhD
- Email: Pooya.r@hotmail.com
- Phone: +4640331000
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Indocyanine green fluorescence during laparoscopic Heller–Dor for achalasia
This study will try using indocyanine green dye during laparoscopic Heller‑Dor in adults with type I or II achalasia to find mucosal leaks during surgery and help guide repairs.
-
Lidocaine Infiltration to See If It Helps Inflammation and Brain Function After Head and Neck Cancer Surgery
This study tests whether different amounts of lidocaine injected into the surgical area can influence inflammation and brain-related outcomes after major head and neck cancer surgery in adults.
-
Online perioperative education to support head and neck cancer patients and their caregivers
This trial tests a digital education program called CareOrbit to see if it improves understanding, satisfaction, and outcomes for adults with head and neck cancer undergoing reconstructive surgery or laryngectomy.
-
Swallowing Rehab Program for Head and Neck Cancer Patients on Chemoradiation
A structured swallowing rehabilitation program is tested to see if it improves swallowing, jaw mobility, and pain for head and neck cancer patients undergoing chemoradiation.
-
Energy needs after head and neck cancer surgery with free flap reconstruction
This study tests how many calories people need before and after free flap surgery for head and neck cancer and whether nutrition relates to recovery and complications.
-
Tests whether far infrared therapy and nerve stimulation help with side effects in head and neck cancer patients receiving chemoradiotherapy
This trial tests if adding far infrared therapy and transcutaneous electrical nerve stimulation to standard care can reduce treatment-related side effects for adults with head and neck cancer undergoing chemoradiotherapy.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.